My watch list
my.chemeurope.com  
Login  

Suproclone



Suproclone
Systematic (IUPAC) name
[6-(7-chloro-1,8-naphthyridin-2-yl)-5-oxo-3,7- dihydro-2H-[1,4]dithiino[2,3-c]pyrrol-7-yl]-4-propanoylpiperazine-1-carboxylate
Identifiers
CAS number 77590-92-2
ATC code  ?
PubChem 53696
Chemical data
Formula C22H22ClN5O4S2 
Mol. mass 520.024 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Suproclone is a sedative and anxiolytic drug in the cyclopyrrolone family of drugs, developed by the French pharmaceutical company Rhône-Poulenc.[1] Other cyclopyrrolone drugs include zopiclone, pagoclone and suriclone.

Additional recommended knowledge

Suproclone is very similar in structure to the related drug suriclone, but little information has been published about it specifically. However it can be expected that the mechanism of action by which suproclone produces its sedative and anxiolytic effects is by modulating benzodiazepine receptors, in a similar manner to other drugs of this class.[1][2]


References

  1. ^ Colin R. Gardner. Pharmacological profiles in vivo of benzodiazepine receptor ligands. Drug Development Research 1988. 12(1):1-28.
  2. ^ Ian L. Martin, Adam Doble, David J. Nutt. Calming the Brain: Benzodiazepines and Related Drugs from Laboratory to Clinic. Informa Healthcare (October 24, 2003). ISBN 1-84184-052-1


 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Suproclone". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE